Search

Search Constraints

You searched for: Author/Creator Maris, Michael

Search Results

3. Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes. Issue 6 (17th January 2017)

4. Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. (2nd March 2015)